Aevice Health Secures $7M Seed Funding to Drive Expansion in Japan and Singapore

Aevice Health, a prominent medtech company specializing in remote monitoring solutions for chronic respiratory conditions, has secured $7 million in an extended seed funding round. The round was led by Coronet Ventures, the venture arm of Cedars-Sinai Intellectual Property (CSIP).

Several key investors participated in the funding round, including East Ventures, A&D Company, NTUitive, Farquhar Venture Capital, and existing backer Silicon Solution Venture. SEEDS Capital, the corporate investment arm of Enterprise Singapore, also joined the round. 

Aevice Health intends to use the recently secured funds to enhance product development and broaden its operations across the U.S., Japan, and Singapore. The startup has already obtained regulatory approvals for its flagship device, the AeviceMD wearable stethoscope, in both the U.S. and Singapore.

In addition to its recent achievements, Aevice Health has established a strategic partnership with Japanese medical equipment manufacturer A&D Company, which involved a $1 million investment. The collaboration is expected to accelerate the company’s market penetration in Japan. 

The startup is also participating in the Cedars-Sinai Accelerator program, which will help it navigate the U.S. clinical, regulatory, and healthcare reimbursement landscapes, further supporting its expansion efforts in the U.S.

The company’s CEO, Adrian Ang, highlighted the pressing need for effective solutions to manage chronic respiratory diseases, a leading cause of mortality worldwide. He emphasized that Aevice Health’s remote monitoring technology addresses a critical gap in patient care. Ang also expressed gratitude for the continued support from both new and existing investors. 

Nirdesh K. Gupta, CEO of Coronet Ventures, commended Aevice Health for its work in the respiratory care market. He noted the company’s strong team and well-established pathways into the U.S. healthcare and distribution networks, positioning it for rapid growth. Gupta expressed his desire to continue to work closely with Aevice Health to ensure its success in the global healthcare landscape.

Over the past few years, Aevice Health has consistently attracted investor interest to advance its wearable respiratory monitoring technology globally. Earlier this year, Aevice Health began collaborating with London-based Jiva.ai to develop an AI system to predict asthma exacerbations.

Founded in 2018, Aevice Health has developed a remote monitoring platform featuring the world’s smallest smart wearable stethoscope. This device continuously monitors patients with chronic respiratory diseases by analyzing heart and lung sounds and tracking vital biomarkers such as respiratory rate, heart rate, and wheezing. 

The platform allows healthcare professionals to conduct comprehensive lung health assessments remotely, using patients’ longitudinal data to detect clinical deterioration early. This technology is particularly vital as chronic respiratory diseases are the third leading cause of death worldwide, affecting millions who often lack access to timely care.

Also Read:

• UnaBiz Secures $25 Million in Pre-Series C Funding to Expand IoT Solutions Globally
• HAII Secures Second Place in Prestigious KHIDI-Roche Diagnostics Day ‘New Impact Project,’ Eyes Global Expansion
• Taiwan’s BBTruck Aims for Global Expansion with $6.5 Million Pre-Series A Funding
• Growsari Secures US$5M Investment to Empower 1.3M Sari-Sari Stores Across the Philippines